title: Ridaforolimus in advanced sarcomas: a leap forward or missed opportunity?
authors.forename: Ignacio
authors.initials: I
authors.lastname: Garrido-Laguna
authors.forename: Filip
authors.initials: F
authors.lastname: Janku
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012509:Sarcoma / Q000188:drug therapy*; D020123:Sirolimus / Q000031:analogs & derivatives*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus